创新医疗（002173）2月6日主力资金净卖出1.39亿元

Core Viewpoint - Innovation Medical (002173) experienced a decline in stock price, closing at 27.56 yuan on February 6, 2026, down 6.1% with a turnover rate of 13.49% and a trading volume of 561,400 hands, amounting to a total transaction value of 1.558 billion yuan [1]. Group 1: Financial Performance - For the first three quarters of 2025, Innovation Medical reported a main revenue of 597 million yuan, a year-on-year decrease of 2.11% [3]. - The net profit attributable to shareholders was 4.7244 million yuan, showing a significant year-on-year increase of 116.97% [3]. - The net profit after deducting non-recurring gains and losses was -29.4698 million yuan, with a year-on-year increase of 6.05% [3]. - In the third quarter of 2025, the company recorded a single-quarter main revenue of 196 million yuan, down 3.16% year-on-year [3]. - The single-quarter net profit attributable to shareholders was 16.0857 million yuan, reflecting a substantial year-on-year increase of 236.15% [3]. - The single-quarter net profit after deducting non-recurring gains and losses was -16.5858 million yuan, down 12.36% year-on-year [3]. - The company's debt ratio stood at 17.84%, with investment income of 29.5055 million yuan and financial expenses of 605,500 yuan, resulting in a gross profit margin of 10.08% [3]. Group 2: Capital Flow - On February 6, 2026, the net outflow of main funds was 139 million yuan, accounting for 8.92% of the total transaction value [1]. - Retail investors saw a net inflow of 134 million yuan, representing 8.62% of the total transaction value [1]. - The financing data indicated a financing buy of 91.3835 million yuan and a financing repayment of 115 million yuan, resulting in a net repayment of 23.2524 million yuan [2]. - The margin trading data showed no shares were sold or repaid, with a remaining margin of 13,700 shares and a margin balance of 377,600 yuan [2]. - The total balance of margin trading and securities lending was 542 million yuan [2].